HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The assessment of human organic cation transporter 1 (hOCT1) mRNA expression in patients with chronic myelogenous leukemia is affected by the proportion of different cells types in the analyzed cell population.

AuthorsZdenek Racil, Filip Razga, Lucie Buresova, Tomas Jurcek, Dana Dvorakova, Daniela Zackova, Shira Timilsina, Petr Cetkovsky, Jiri Mayer
JournalAmerican journal of hematology (Am J Hematol) Vol. 85 Issue 7 Pg. 525-8 (Jul 2010) ISSN: 1096-8652 [Electronic] United States
PMID20575042 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Benzamides
  • Organic Cation Transporter 1
  • Piperazines
  • Pyrimidines
  • RNA, Messenger
  • RNA, Neoplasm
  • Imatinib Mesylate
Topics
  • Benzamides
  • Drug Monitoring (methods, standards)
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive (drug therapy, pathology)
  • Leukocyte Count
  • Leukocytes (cytology)
  • Leukocytes, Mononuclear
  • Neutrophils
  • Organic Cation Transporter 1 (genetics)
  • Piperazines (pharmacokinetics, therapeutic use)
  • Pyrimidines (pharmacokinetics, therapeutic use)
  • RNA, Messenger (analysis)
  • RNA, Neoplasm (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: